Yue Eddy W, Higley C Anne, DiMeo Susan V, Carini David J, Nugiel David A, Benware Carrie, Benfield Pamela A, Burton Catherine R, Cox Sarah, Grafstrom Robert H, Sharp Diane M, Sisk Lisa M, Boylan John F, Muckelbauer Jodi K, Smallwood Angela M, Chen Haiying, Chang Chong-Hwan, Seitz Steven P, Trainor George L
Bristol-Myers Squibb Company, Experimental Station, P.O. Box 80500, Wilmington, Delaware 19880-0500, USA.
J Med Chem. 2002 Nov 21;45(24):5233-48. doi: 10.1021/jm0201722.
The identification of indeno[1,2-c]pyrazol-4-ones as inhibitors of cyclin-dependent kinases (CDKs) has led to the discovery of a series of novel and potent compounds. Herein, we report the effects of substitutions at C3 of the indeno[1,2-c]pyrazol-4-one core with alkyls, heterocycles, and substituted phenyls. Substitutions at the para position of the phenyl ring at C3 were generally well-tolerated; however, larger groups were generally inactive. For alkyls directly attached to C3, longer chain substituents were not tolerated; however, shorter alkyl groups and cyclic alkyls were acceptable. In general, the heterocycles at C3 gave the most potent analogues. One such heterocycle, 24j, was examined in detail and was determined to have a biological profile consistent with CDK inhibition. An X-ray crystal structure of one of the alkyl compounds, 13q, complexed with CDK2 was determined and showed the inhibitor residing in the adenosine 5'-triphosphate pocket of the enzyme.
茚并[1,2-c]吡唑-4-酮作为细胞周期蛋白依赖性激酶(CDK)抑制剂的鉴定导致了一系列新型强效化合物的发现。在此,我们报告了茚并[1,2-c]吡唑-4-酮核心结构C3位被烷基、杂环和取代苯基取代后的影响。C3位苯环对位的取代通常耐受性良好;然而,较大的基团通常无活性。对于直接连接在C3位的烷基,较长链的取代基不能耐受;然而,较短的烷基和环烷基是可以接受的。一般来说,C3位的杂环产生了最有效的类似物。对其中一种杂环化合物24j进行了详细研究,确定其生物学特性与CDK抑制作用一致。测定了一种烷基化合物13q与CDK2复合的X射线晶体结构,结果显示抑制剂位于该酶的腺苷5'-三磷酸口袋中。